Autoinjector or syringe? study tests how ADL-018 enters the body
NCT ID NCT06929052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving ADL-018 with an autoinjector works the same as with a syringe. 150 healthy adults received a single dose under the skin. The goal was to compare how the drug enters the bloodstream and check for safety. This is an early-stage study, not meant to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ADL-018
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cliantha Research
Mississauga, ON L4W 1A4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill help regulate blood sugar? early trial puts PSTC100 to the test
- First human trial launches for experimental PSTB100 drug
- Syringe showdown: does a prefilled device deliver drug as well as a vial?
- Healthy volunteers help unlock the Body's handling of a new drug
- New edaravone tablet tested in healthy volunteers
- Healthy volunteers test new Drug's body processing